
ãã§ã€ã¹ããã¯ãCOVIDã¯ã¯ãã³ãå ç«ç³»ãç Žå£ããæ°åãšã€ãºãåŒãèµ·ããããšãèªãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
2022幎8æãThe Exposeã¯ãè±åœå¥åº·å®å šä¿éå±ãçºè¡šãã5ã¶æåã®è±åœæ¿åºã®å ¬åŒããŒã¿ã«é¢ããç¬å çãªè©³çŽ°èª¿æ»ãçºè¡šããã³ããã19ãããŒã¹ã¿ãŒãæäžã®ãã³ã«ã被æ¥çš®è ã®å ç«ç³»ã«éåžžã«çæéã§äžæçã«ããŒã¹ãããããããã®åŸãã³ããã19ã¯ã¯ãã³ã2åæ¥çš®ãã人ã ã«ãã§ã«èŠããããããã¯ããã«æ¥éã«å ç«ç³»ã壿» ãããããšã確èªããŸããã
ã€ãŸããè±åœæ¿åºã®å ¬åŒããŒã¿ã¯ãã³ããã19ã¯ã¯ãã³ãæ¥çš®ãã人ã ããã³ããã19ã¯ã¯ãã³èªçºã®åŸå€©æ§å ç«äžå šçåçŸ€ã®æ°ãã圢æ ãçºçããŠããããšã匷ã瀺åããŠããããšãçºèŠããã®ã§ãã

ãã®èª¿æ»ã¯ãç§ãã¡ãèšäºãå ¬éããåãæ¥ã«ãèªè ãFacebookäžã§å ±æãããã®ã§ãFacebookã¯ãã®æçš¿ãçŽã¡ã«åé€ãããèª€å ±ããšè¡šç€ºããŸããã
ããããç§ãã¡ã®èšäºãã·ã§ã¢ããèªè ã¯Facebookã®æ€é²ã«ç°è°ãå±ãã10æ27æ¥ã«ããããFacebookã¯ãèªåãã¡ãå®éã«ééã£ãŠããããšã調æ»ã¯å®å šã«æ£ããã£ãããšããããŠèªè ã®Facebookã®æçš¿ããæ€é²ã®å³ãããœãŒã·ã£ã«ã¡ãã£ã¢ã»ãã©ãããã©ãŒã ã«æ»ã£ãããšã確èªããããã«åçããŠãããŸããã

ããã§ãThe Exposeã1幎以äžã«ããã£ãŠåºãäžè¬ã«äŒããããšããŠããããšãFacebookã確èªããããããã®èšäºãåºãå ±æããŠããã ããããã以äžã«ãªãªãžãã«ã®èª¿æ»çµæããã¹ãŠæ²èŒããŸããã
è±åœå¥åº·å®å šä¿éå±ïŒUKHSAïŒã¯ããã€ãŠæ¯é±ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžãçºè¡ããŠãããåå ±åæžã«ã¯ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã«ã³ããã19ã®çäŸãå ¥é¢ãæ»äº¡ã«é¢ãã4é±éåã®ããŒã¿ãå«ãŸããŠããŸããä»åã®èª¿æ»ã§ã¯ãã³ããã19ã¯ã¯ãã³ãæ¥çš®è ã®å ç«ç³»ã«äžãã圱é¿ãæç¢ºã«ææ¡ããããã2021幎8æ16æ¥ãã2022幎1æ2æ¥ãŸã§ã®ããŒã¿ãå«ãããããã®å ¬è¡šãããã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã®ãã¡5ã€ãåæããŸããã
ç§ãã¡ã®èª¿æ»ã«äœ¿çšãããUKHSAã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã¯ããã¹ãŠããã§èŠãããšãã§ããŸãã
Covid-19 Vaccine Surveillance Report - Week 37ãïŒPHEçºè¡ïŒ
Covid-19ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒã第41é±ãïŒUKHSAçºè¡ïŒ
ã³ããã19ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒã-45é±ç®-ãïŒUKHSAçºè¡ïŒ
ã³ããã19ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒã-49é±ç®-ãïŒUKHSAçºè¡ïŒ
Covid-19ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒã-第1é±ïœ2022幎ãïŒUKHSAçºè¡ïŒ
ãªã¢ã«ã¯ãŒã«ãã®Covid-19ã¯ã¯ãã³ã®æå¹æ§
ãã¡ã€ã¶ãŒç€Ÿã¯ãã³ããã19 mRNA泚å°ã®ã¯ã¯ãã³å¹æã¯95ïŒ ã§ãããšäž»åŒµããŠãããããã¯ãçŸåšãé²è¡äžã®èšåºè©Šéšã®åææ®µéã«ãããŠãã¯ã¯ãã³ãæ¥çš®ããã°ã«ãŒããšæ¥çš®ããŠããªãã°ã«ãŒãã§ç¢ºèªãããææçã®æ°ã«ã€ããŠãç°¡åãªèšç®ïŒãã®è©³çްã«ã€ããŠã¯ããã¡ããã芧ãã ããïŒãè¡ã£ãçµæããã®ããã«äž»åŒµããããšãã§ããŸããã
ä»åãè±åœå¥åº·å®å šä¿éå±ãçºè¡šããè±å¯ãªããŒã¿ã®ãããã§ããã¡ã€ã¶ãŒç€Ÿè£œã¯ã¯ãã³ã®95ïŒ æå¹æ§ãç®åºããã®ãšåãèšç®ã§ãCovid-19ã¯ã¯ãã³ã®çŸå®ã®æå¹æ§ãç®åºããããšãã§ããããã«ãªããŸããã
37é±ç®ã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã«ã¯ã2021幎第33é±ãã第36é±ïŒ8æ16æ¥ãã9æ12æ¥ïŒãŸã§ã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19ã®çäŸæ°ãèšèŒãããŠããŸããããã®ã¬ããŒãã§ã¯ãã¯ã¯ãã³æªæ¥çš®è ãš2åæ¥çš®è ã®10äžäººãããã®Covid-19çäŸçããããã®ã§ããã®æéã®çŸå®ã®ã¯ã¯ãã³å¹æãèšç®ããããšãã§ããããã¯ä»¥äžã®ããã«èšŒæãããŸããã

å ¥æå¯èœãªãã¹ãŠã®Covid-19ã¯ã¯ãã³ãåãããçŸå®ã®å¹æã¯ã2021幎8æ16æ¥ãã9æ12æ¥ã®éã«ã60ïœ69æ³ã®å¹Žéœ¢å±€ã§ãã€ãã¹47ïŒ ãšäœãã18æ³æªæºã®å¹Žéœ¢å±€ã§ãã©ã¹66ïŒ ãšé«ããªããŸããããã®æç¹ã§ã¯ã¯ãã³ããã©ã¹ã®å¹æã瀺ããŠããä»ã®å¹Žéœ¢å±€ã¯ã18ïœ29æ³ã30ïœ39æ³ã80æ³ä»¥äžã ãã§ãããããããã©ã®å¹Žéœ¢å±€ã95%ã«è¿ãã¯ã¯ãã³å¹æã瀺ããŠããªãããšããåããããã ãããšæããŸãã
ãããããã®1ãµæåŸãç¶æ³ã¯äžå€ããŠããŸãã
41é±ç®ã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã§ã¯ã2021幎第37é±ãã第40é±ïŒ9æ13æ¥ïœ10æ10æ¥ïŒãŸã§ã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19çäŸæ°ãå ±åãããŠããããã®éã®çŸå®ã®ã¯ã¯ãã³å¹æã¯ä»¥äžã®ããã«èšŒæãããŠããã®ã§ãã

å©çšå¯èœãªãã¹ãŠã®Covid-19ã¯ã¯ãã³ãåãããçŸå®ã®å¹æã¯ã2021幎9æ13æ¥ãã10æ10æ¥ã®éã«ã40-49æ³ã®å¹Žéœ¢å±€ã§ãã€ãã¹109ïŒ ãšäœãã18æ³æªæºã®å¹Žéœ¢å±€ã§+89ïŒ ãšé«ãå€ã瀺ããŸããããã®æç¹ã§ã¯ã¯ãã³ããã©ã¹ã®å¹æã瀺ããŠããã®ã¯ã18ïœ29æ³ã®å¹Žéœ¢å±€ã ãã ã£ãã®ã§ãã
ããããããã§æ°ã«ãªãã®ã¯ããã¹ãŠã®å¹Žéœ¢å±€ã§ã¯ã¯ãã³ã®å®å¹çãäœäžããŠããããšã§ãç¹ã«40-49æ³ã§ã¯å®å¹çããã€ãã¹36%ãããã€ãã¹109%ã«äœäžããŠããã
çŸå®ã®æå¹çããã€ãã¹100ïŒ ã®å£ãè¶ ãããšããããšã¯ãã¯ã¯ãã³ã倱æããŠããã ãã§ãªãã被æ¥çš®è ã®å ç«ç³»ãå®å šã«åŽ©å£ãããŠããããšã瀺åããŠããŸãã
ãããªããšã次ã®ã¯ã¯ãã³ã»ãµãŒãã€ã©ã³ã¹ã»ã¬ããŒããæããããªã£ãŠããã
第45é±ã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åã«ã¯ã2021幎第41é±ãã第44é±ïŒ10æ11æ¥ãã11æ7æ¥ïŒãŸã§ã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®Covid-19çäŸæ°ãèšèŒãããŠããããã®æéã®çŸå®ã®ã¯ã¯ãã³å¹æã¯ã以äžã®ããã«èšŒæãããŠãã---ã

å©çšå¯èœãªãã¹ãŠã®Covid-19ã¯ã¯ãã³ãåãããçŸå®ã®å¹æã¯ã2021幎10æ11æ¥ãã11æ7æ¥ã®éã«ã40-49æ³ã®å¹Žéœ¢å±€ã§ãã€ãã¹126ïŒ ãšäœãã18æ³æªæºã®å¹Žéœ¢å±€ã§+78ïŒ ãšé«ãå€ã瀺ããŸããããã®æç¹ã§ã¯ã¯ãã³ããã©ã¹ã®å¹æã瀺ããŠããä»ã®å¹Žéœ¢å±€ã¯ããã¯ã18ïœ29æ³ã ãã§ããã
ããã§æ°ã«ãªãã®ã¯ã50-59æ³ããã€ãã¹116ïŒ ã60-69æ³ããã€ãã¹120ïŒ ãšãããã«2ã€ã®å¹Žéœ¢å±€ããã€ãã¹100ïŒ ã®å£ãçªç Žããããšã ããããããã以äžã«æ°ã«ãªãã®ã¯ãåæã«ãã§ã«ãã€ãã¹100ïŒ ã®å£ãè¶ ãã40ïœ49æ³ã®å¹Žéœ¢å±€ã§ãã³ããã19泚å°ã®æå¹æ§ãäœäžãç¶ããŠããããšã§ãã
ãŸãã80æ³ä»¥äžã®ã³ããã19泚å°ã®æå¹çããã€ãã¹22ïŒ ãããã€ãã¹9ïŒ ã«äžæããŠããããšãããããŸããããã¯ããã®å¹Žéœ¢å±€ãžã®ããŒã¹ã¿ãŒãžã£ãã®å±éãšäžèŽããã¯ã¯ãã³ãå®éã«å ç«ç³»ãé«ããããšã瀺åããŠããŸãããããããã®å¹Žéœ¢å±€ã§ã¯ãŸã ãã€ãã¹ã®æå¹æ§ãããã2021幎ã®33é±ãš36é±ã®éã«èŠããããã€ãã¹3ïŒ ã®æå¹æ§ããããŸã äœãããšã¯æ³šç®ã«å€ããŸãã
ãããã49é±ç®ã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒãã¯ãçæçã«ããŒã¹ã¿ãŒã被æ¥çš®è ã«äžãã广ã«ã€ããŠãããæç¢ºãªã€ã¡ãŒãžãæäŸããŠããŸãã
第49é±ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã«ã¯ã2021幎第45é±ãã第48é±ïŒ11æ8æ¥ãã12æ5æ¥ïŒãŸã§ã®æ¥çš®ç¶æ³å¥ã®Covid-19çäŸæ°ãèšèŒãããŠããããã®æéã®çŸå®ã®ã¯ã¯ãã³å¹æã¯ä»¥äžã®ããã«èšŒæãããã

å ¥æå¯èœãªãã¹ãŠã®Covid-19ã¯ã¯ãã³ãåãããå®äœ¿çšå¹æã¯ã2021幎11æ8æ¥ãã12æ5æ¥ã®éã«ã40ïœ49æ³ã®å¹Žéœ¢å±€ã§ã¯ãã€ãã¹120ïŒ ã18æ³æªæºã®å¹Žéœ¢å±€ã§ã¯ãã©ã¹80ïŒ ãšäœããªã£ãŠããŸããCovid-19泚å°ã®çŸå®ã®å¹æã¯ãå®ã¯ãã®4é±éã®éã18ïœ29æ³ãš30ïœ39æ³ã§ããäœäžããªãã£ãã®ã§ãã
70æ³ä»¥äžã®æ¹ã¯ããã®4é±éã§å ç«åãå€§å¹ ã«åäžãã70ïœ79æ³ã®æ¹ã§ã¯ã10æ11æ¥ãã11æ7æ¥ã®éã«ãã€ãã¹84%ã ã£ãã¯ã¯ãã³å¹æãã11æ8æ¥ãã12æ5æ¥ã®éã«ãã©ã¹27%ã«ãªã£ãããšã蚌æãããŸããã
äžæ¹ã80æ³ä»¥äžã®æ¹ã®ã¯ã¯ãã³å¹æã¯ã10æ11æ¥ãã11æ7æ¥ãŸã§ã®ãã€ãã¹9ïŒ ã«å¯Ÿãã11æ8æ¥ãã12æ5æ¥ãŸã§ã®éã«+47ïŒ ã«å¢å ããŸããã
ãŸãã40æ³ãã69æ³ã®æ¹ãããã®æéã«å ç«åãåäžããŸããããã¯ã¯ãã³ã®æå¹æ§ã瀺ãã«ã¯ååã§ã¯ãããŸããã§ããããã®ã¯ã¯ãã³å¹æã®äžæã¯ãUKHSAã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒã-第1é±-2022ããåŒçšãã以äžã®ã°ã©ãã«èŠãããããã«ãå幎霢局ã«ããŒã¹ã¿ãŒã·ã§ããã宿œãããææãšäžèŽããŠããŸãã

70æ³ä»¥äžã§ã¯ã¯ã¯ãã³å¹æããã€ãã¹ãšãããŠããã®ããããŒã¹ã¿ãŒæ¥çš®åŸã¯å šå¡ãã©ã¹ã«è»¢ããããšãããæ¬¡åçºè¡šã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã§ã¯ã40ïœ69æ³ã®ã¯ã¯ãã³å¹æãå€§å¹ ã«æ¹åããããšäºæ³ãããŸãã
ããããæ®å¿µãªãããããªã£ãŠããªãã
第1é±-2022-ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹å ±åæžã«ã¯ã2021幎第49é±ãã第52é±ïŒ12æ6æ¥ãã1æ2æ¥ïŒãŸã§ã®æ¥çš®ç¶æ³å¥Covid-19çäŸæ°ãèšèŒãããŠããããã®æéã®å®éã®ã¯ã¯ãã³å¹æã¯ä»¥äžã®ããã«èšŒæãããã®ã§ãã

çŸå®ã®ã¯ã¯ãã³å¹æã¯ã12æ6æ¥ãã1æ2æ¥ã«ãããŠã70æ³ä»¥äžãé€ããã¹ãŠã®å¹Žéœ¢å±€ã§ãããŸã§ã§æãäœãæ°ŽæºãŸã§äœäžããŸãããã70æ³ä»¥äžã§ã¯äŸç¶ãšããŠãã€ãã¹å¹æã«èœã¡èŸŒãã§ããŸãã
40ïœ69æ³ã§ã¯ããããªã广ã¢ãããæåŸ ããããå®çŸããã代ããã«40ïœ49æ³ã§ã¯-151%ãŸã§äœäžããã¯ã¯ãã³å¹æã®å€§è»¢èœãèšé²ããã
ãŸã30ïœ39æ³ã®å¹Žéœ¢å±€ã§ã¯ã49é±ç®ã«æ°çŸäžäººã«ããŒã¹ã¿ãŒãžã£ããæäžãããã«ãããããããã¯ã¯ãã³å¹æã¯ãã€ãã¹123%ã«èœã¡ãŸããã
以äžã®ã°ã©ãã¯ã21幎8æ16æ¥ãã22幎1æ2æ¥ãŸã§ã®5ã¶æéãå幎霢局ã«ãããæå¥ã®ã¯ã¯ãã³å¹æã®å¢æžã瀺ãããã®ã§ããã

æåã®ããŒã¹ã¿ãŒã·ã§ããã¯2021幎ã®37é±ç®ã«å®æœãããŸãããããã®ã°ã©ãã¯ããã®åŸã®2ã¶æéã§ã¯ã¯ãã³å¹æã®ããŒã¹ãããããããããšãæç¢ºã«ç€ºããŠããŸããããããæ®å¿µãªããšã«ããã®ããŒã¹ããããã«çæéã§ãã£ããã瀺ããŠããã49é±ç®ãã52é±ç®ã«ãããŠã³ããã19ã¯ã¯ãã³ã®æå¹æ§ã¯æãããã¬ãã«ãŸã§äœäžããŠããŸãã
ããããå®éã«ã¯ã¯ãã³å¹æã®ãã©ã¹ã»ãã€ãã¹ã¯ã©ã®ãããªæå³ãæã€ã®ã§ããããã
ã¯ã¯ãã³ã¯ããŠã€ã«ã¹ã«ããæ»æãã·ãã¥ã¬ãŒãããŠãå ç«ç³»ãåºæ¿ãããŠã€ã«ã¹ã«ææãããã®ããã«åå¿ãããããšã§å¹æãçºæ®ããŸãããã®çµæããŠã€ã«ã¹ã«å¯Ÿããèªç¶å ç«ãç²åŸãããšãããŸã§å ç«ç³»ãèšç·Žããããšãã§ããã®ã§ãããããã£ãŠãã¯ã¯ãã³ã®æå¹æ§ã¯ãã¯ã¯ãã³ã«ãã£ãŠèªå°ãããå ç«ç³»ã®æ§èœãç€ºãææšãšãªããŸãã
ã¯ã¯ãã³å¹æãïŒ50ïŒ ã§ããã°ãå®å šæ¥çš®è ã¯ã¯ã¯ãã³æªæ¥çš®è ã«æ¯ã¹ãŠã³ãã19ã«å¯ŸããŠ50ïŒ ä»¥äžé²åŸ¡ãããŠããããšã«ãªããŸããèšãæããã°ãã¯ã¯ãã³æ¥çš®ãåãã人ã¯ãCovid-19ã«å¯Ÿæããå ç«ç³»ã50ïŒ åäžããŠããããšã«ãªãã
ã¯ã¯ãã³å¹æã0ïŒ ã§ããã°ãå®å šæ¥çš®è ã¯ã¯ã¯ãã³æªæ¥çš®è ãããCovid-19ã«å¯Ÿããé²åŸ¡åã0ïŒ ã§ãããã¯ã¯ãã³ã¯ç¡å¹ã§ããããšãæå³ããŸããèšãæããã°ãå®å šãªã¯ã¯ãã³æ¥çš®ãåãã人ã¯ãã¯ã¯ãã³æªæ¥çš®ã®äººãšåçã®å ç«ã·ã¹ãã ã§Covid-19ã«å¯ŸåŠããŠããããšã«ãªãã
äžæ¹ãã¯ã¯ãã³ã®æå¹æ§ã-50ïŒ ã§ããã°ãã¯ã¯ãã³æªæ¥çš®è ã¯å®å šæ¥çš®è ããã50ïŒ Covid-19ãé²ããããšã«ãªããã¯ã¯ãã³ã¯å®éã«å ç«ç³»ãç Žå£ããããšã«ãªãã
ãããã£ãŠãã€ã³ã°ã©ã³ãã®18æ³ä»¥äžã®ãã¹ãŠã®äººã«ãããŠãCovid-19ã¯ã¯ãã³ã®çŸå®ã®æå¹æ§ããã€ãã¹ã§ããããšã蚌æãããããã2å/3åæ¥çš®ããæäººã®å ç«ã·ã¹ãã ãç Žå£ãããŠããããšãæå³ããŸãã
å ç«ç³»ããã©ãŒãã³ã¹
Covid-19ã¯ã¯ãã³ã®çŸå®ã®æå¹æ§ãèšç®ããããã«äœ¿çšãããèšç®åŒã¯ããã¡ã€ã¶ãŒç€Ÿãèªç€Ÿã®ã¯ã¯ãã³ã®æå¹æ§ã95ïŒ ã§ãããšäž»åŒµããããšã蚌æããããã«äœ¿çšããæ£ç¢ºãªèšç®ã«åºã¥ããŠããŸãã
U = ã¯ã¯ãã³æªæ¥çš®è
ã®çäŸæ°
V = å®å
šæ¥çš®è
ã®çäŸæ°
U - V / U = ã¯ã¯ãã³æå¹ç
ããããå
ç«ã·ã¹ãã ã®æ§èœãèšç®ããããã«ã¯ãU-Vã®çãããã¯ã¯ãã³æªæ¥çš®è
ãšå®å
šæ¥çš®è
ã®ã©ã¡ããã®çäŸæ°ã®æå€§å€ã§å²ããšãããå°ãå€ãã£ãèšç®ãããå¿
èŠããããŸãã
ãããã£ãŠãå ç«ç³»ã®æ§èœããã©ã¹ã«ãªãããã®èšç®æ¹æ³ã¯
U - V / U
äžæ¹ãå ç«ç³»ã®æ§èœããã€ãã¹ã§ããå Žåã®èšç®ã¯ã-U - V / VãšãªããŸãã
U - V / V
次ã®è¡šã¯ãã¯ã¯ãã³æ¥çš®è ã®å ç«ã·ã¹ãã ãšãã¯ã¯ãã³æªæ¥çš®è ã®èªç¶å ç«ã·ã¹ãã ãšã®æ¯èŒã«ããããæããšã®å ç«ã·ã¹ãã ã®åäž/äœäžã瀺ããŠããŸãã

ããã«ãããšã2021幎1æ2æ¥ïŒ5ã¶æç®ïŒçŸåšãããªãã«ïŒããã«ã¯ã¯ãã³æ¥çš®ã®40ïœ49æ³ã¯ãå ç«ç³»ã®ããã©ãŒãã³ã¹ã-60ïŒ ãšææªã§ããããšãããããŸããããããã30ïœ39æ³ã¯-58ïŒ ã18ïœ29æ³ãš50ïœ59æ³ã¯-55ïŒ ã60ïœ69æ³ã¯-47ïŒ ãšãå å·®ã§ç¶ããŠããŸãã
次ã®ã°ã©ãã¯ãéå»5ã¶æéã®ã€ã³ã°ã©ã³ãã®å šå¹Žéœ¢å±€ã«ãããç·åçãªå ç«ã·ã¹ãã ã®ããã©ãŒãã³ã¹ã瀺ããŠããŸãã

äžèšãããããããšã¯ã18æ³ãã59æ³ã®æäººã®å ç«ã·ã¹ãã ã®æ§èœã¯ãã³ããã19ã¯ã¯ãã³ãæ¥çš®ããŠä»¥æ¥ãææªã®ã¬ãã«ãŸã§æªåããŠãããšããããšã§ããäžæ¹ã60æ³ä»¥äžã®æäººã®å ç«ç³»ã¯ã37é±ç®ãã40é±ç®ã«ãããŠã®ã¬ãã«ã«ã¯éããŠããŸããããããŒã¹ã¿ãŒã·ã§ããã®æ¥çš®åŸã«åçã«æªåããŠããŸãã
ãããã70æ³ä»¥äžã®æ¹ã ã¯ã18ïœ29æ³ã®æ¹ã ãšäžŠãã§ã4ã¶æç®ãš5ã¶æç®ã®éã«å ç«ç³»ã®ããã©ãŒãã³ã¹ãæãåçã«äœäžããŠããŸãã

80æ³ä»¥äžã®æ¹ã¯ã3ã¶æç®ãã4ã¶æç®ã«ãããŠããŒã¹ã¿ãŒã§55ïŒ åäžããå ç«åãã4ã¶æç®ãã5ã¶æç®ã«ãããŠå šãŠäœäžããŠããŸãã 3ã¶æç®ã«æ¯ã¹ãŠ1ïŒ åäžããŠããŸãããããã§ãã¯ã¯ãã³æªæ¥çš®ã®æ¹ãšæ¯ã¹ããš54ïŒ äœäžããŠããŸãã
70ïœ79æ³ã§ã¯ã3ã¶æç®ãã4ã¶æç®ã«ãããŠããŒã¹ã¿ãŒã§73ïŒ ã®å ç«ååäžãèŠããããã4ã¶æç®ãã5ã¶æç®ã«ãããŠã¯ã»ãŒæªåãã3ã¶æç®ã«æ¯ã¹ãŠ10ïŒ åäžããŠããããããã§ãã¯ã¯ãã³æªæ¥çš®ã®äººãšæ¯ã¹ãŠ63ïŒ æªåããŠããã
äžæ¹ã30æ³ãã59æ³ã®äººã¯ã3ã¶æç®ãã4ã¶æç®ã«ãããŠããŒã¹ã¿ãŒã§å ç«åããããã«é«ããããç¿æã«ã¯å®å šã«äœäžãã18æ³ãã29æ³ã®äººã¯4ã¶æç®ãš5ã¶æç®ã§å ç«åã60ïŒ äœäžããŠããããšãããã£ãã
以äžã®ã°ã©ãã¯ãéå»5ãµæéã®ã€ã³ã°ã©ã³ãã®å šå¹Žéœ¢å±€ã«ãããå ç«ã·ã¹ãã ã®æ§èœã®åäž/äœäžã瀺ããŠããŸãã

Covid-19ã¯ã¯ãã³èªçºåŸå€©æ§å ç«äžå šçå矀
ã³ããã19泚å°ã®çŸå®ã®å¹æã¯çæéã§èããäœäžããŸãããæ®å¿µãªããã¯ã¯ãã³æ¥çš®ãåãã人ãã¡ã¯ãå ç«ã·ã¹ãã ãæ¥çš®åãšåãç¶æ ã«æ»ãã©ããããå ç«ã·ã¹ãã ã®æ§èœãæ¥éã«äœäžãå§ããã¯ã¯ãã³æªæ¥çš®ã®äººãã¡ã«æ¯ã¹ãŠå£ã£ãŠããŸãã®ã§ãã
è±åœæ¿åºã®å ¬åŒããŒã¿ã§ã¯ãã¯ã¯ãã³ã®ããŒã¹ã¿ãŒæäžã被æ¥çš®è ã®å ç«ç³»ãçæçã«é«ããããšã蚌æãããŠããŸãããæ®å¿µãªããããã®åãããŒã¿ã§ã¯ããã®åŸãå ç«ç³»ã®æ§èœã¯ããŒã¹ã¿ãŒæäžåãããããã«æ¥éã«äœäžãå§ããããšã瀺ãããŠããŸãã
ãããã£ãŠããã®ããŒã¿ã¯ãã¯ã¯ãã³æ¥çš®ãåãã人ã ããã¯ã¯ãã³æ¥çš®ãåããŠããªã人ã ããå£ãããšãªããå ç«ç³»ãé«ããããã«ãããŒã¹ã¿ãŒæ³šå°ãç¡éã«ç¹°ãè¿ãå¿ èŠãããããšã瀺åããŠããã
åŸå€©æ§å ç«äžå šçå矀ã¯ãå ç«çްèã倱ãããä»ã®ææçãããçš®ã®çã®çºçã«ãããããããªãç æ°ã§ããã€ãŸããå ç«ç³»ãå®å šã«ç Žå£ããŠããŸãã®ã§ãã
ã§ã¯ãCovid-19ã¯ã¯ãã³ã«ããåŸå€©æ§å ç«äžå šçå矀ã®å¯èœæ§ã¯ããã®ã ãããã
è±åœæ¿åºãåœå®¶çµ±èšå±ãéããŠçºè¡šããææ°ã®æ°åã«ãããšãã¯ã¯ãã³æ¥çš®ãåããŠããªã人ã®10äžäººãããã®æ»äº¡çã¯ããã¹ãŠã®å¹Žéœ¢å±€ã§ã¯ã¯ãã³æ¥çš®ãåããäººã«æ¯ã¹ãŠæãäœããšããçµæãåºãŠããããšãèãããšã確ãã«ãã®ããã«æãããŸãã
